Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty comple
about
DNA methylation maintains allele-specific KIR gene expression in human natural killer cellsPolymorphism in clinical immunology - From HLA typing to immunogenetic profilingHLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptorsGenetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice.Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifPrimate-specific regulation of natural killer cells.Biology of natural killer cells in cancer and infection.Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications.Variable NK cell receptors exemplified by human KIR3DL1/S1Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysisRoles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)Taking license with natural killer cell maturation and repertoire development.Natural killer cell inhibitory receptor expression in humans and mice: a closer look.Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology.Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution.Clinical relevance of natural killer cells following hematopoietic stem cell transplantation.KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs.KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement.Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells.Host MHC class I gene control of NK-cell specificity in the mouse.Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.Killer cell receptors: keeping pace with MHC class I evolution.Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles.HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model.Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type.Having it both ways: MHC recognition in cis and trans.Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.Large Granular Lymphocyte Leukemia/Lymphoma in Six CatsStructural Differences in KIR3DL1 and LILRB1 Interaction with HLA-B and the Loading Peptide Polymorphisms:In SilicoEvidences
P2860
Q24673791-CB9A9F59-0AE9-41A4-A75B-76758DF13145Q24798836-1EC0ED75-8CE4-4BBF-A9AB-BD8EB22FE048Q28298119-B99AF924-6FDA-4DC7-B776-6EF297FB53D3Q33384422-BFD13583-154C-47B2-BEB6-2EAF62608F29Q33474773-165896BD-68D8-49B4-A424-F8EFA6684851Q33682888-1421EA43-DA8F-4007-AC52-A6067A06A652Q33851496-B6C23C7F-F2F9-47FE-9E42-D925F0F59F20Q34064807-BFB8A788-BD4F-4632-8F5A-4FC4D7A95BB5Q34651546-3F801D62-A6D6-4CA2-8D88-7940CF72E308Q35567805-7EF0D254-0CB4-4916-B25D-69397DEB7546Q35570313-2FA85CC1-3DA9-4389-BAA8-E6108C79CDD3Q35847425-8417392C-0C06-41B7-AE93-FE050BD9827EQ35847508-537434F0-26D5-4D78-BCA3-D5729F60C764Q35919640-4C379FF9-97BE-42E8-BAC1-B2487DC6DD5CQ36228467-D2E6D575-04F1-4A60-92F2-A5F0DD220153Q36301388-4BF547B1-A09B-4BE7-8155-57267553D611Q36381019-62992220-1523-4956-89CC-EC892AF003ACQ36652192-D6739926-78F5-40FF-A3E8-856B7D4CB7BAQ36715233-900F0AB2-2E07-40BC-8880-176FA174CF78Q37622486-6E1C6923-5D99-4A17-8596-725351D1AE73Q37641722-09E04883-7B92-47B6-B183-002C43740111Q38079585-07FF8EA5-D688-4CD6-B15E-85088FFE4F65Q38703075-429D8689-5743-4CDB-82F8-12EA9C5BACC4Q38732620-3D0C58C1-1EAA-4D29-9A72-37CCDAD83A2FQ39068732-AE023015-6C5C-43D7-AFBE-678BAEB7608CQ40902154-5955DB0B-4C9F-4D6E-9CE5-C9F3EF70D6C0Q41128555-68CA5795-04D9-4A2F-974F-1C5A8B1FAF24Q41373608-3597134A-EA33-4651-8B64-E8251BB3C711Q41373707-4860EE86-AB8C-4D86-B893-0B7E1B50BA16Q41373744-DFD12FA0-EAD9-40AF-9C34-974AD03F0A65Q41373758-B295E77B-DF1A-4681-A8FB-0D78A9B4E057Q41769326-F796B15B-07F4-49E1-87D9-D71496CE26A9Q42943674-CA8D20F6-3141-48A8-B876-AD12336232B1Q42945170-7444EDBE-3346-4505-BA00-7E63AF25F779Q43646040-995B2E0C-B20D-4C0D-8BBD-44FFE08B6B3BQ48033283-24C53BA1-0CB3-4173-911C-E939C66BACEBQ51996024-41FA4033-87BD-44DD-BE53-C6842C7ACC27Q53554158-E37E245F-DCE3-42F9-853C-55C7B2FFBEEBQ57607212-DC070010-0318-426B-A95F-F9739A6532ACQ59103272-25614410-ADAC-48FE-B644-ED2E631BE1E3
P2860
Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty comple
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@ast
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@en
type
label
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@ast
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@en
prefLabel
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@ast
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@en
P2093
P2860
P356
P1476
Heterogeneous phenotypes of ex ...... jor histocompatibililty comple
@en
P2093
P2860
P304
P356
10.1084/JEM.183.4.1817
P407
P577
1996-04-01T00:00:00Z